KORU Medical Systems, Inc. Common Stock (DE) (KRMD) is a publicly traded Healthcare sector company. As of May 21, 2026, KRMD trades at $4.00 with a market cap of $175.92M and a P/E ratio of -80.40. KRMD moved +1.14% today. Year to date, KRMD is -28.19%; over the trailing twelve months it is +35.59%. Its 52-week range spans $1.86 to $6.61. Analyst consensus is strong buy with an average price target of $6.75. Rallies surfaces KRMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
KORU Medical Posts 22% Revenue Growth to $41.1M, International Sales +71%: KORU Medical Systems delivered full-year revenue growth of 22% to $41.1 million, with international core sales up 71% and EU MDR certification for its Freedom 60 device. PST business fell 30% on contract timing, gross margin slipped 30 basis points, and a CEO transition was announced with 2026 guidance initiated.
| Metric | Value |
|---|---|
| Price | $4.00 |
| Market Cap | $175.92M |
| P/E Ratio | -80.40 |
| EPS | $-0.05 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.61 |
| 52-Week Low | $1.86 |
| Volume | 1.27K |
| Avg Volume | 0 |
| Revenue (TTM) | $43.26M |
| Net Income | $-2.28M |
| Gross Margin | 61.93% |
5 analysts cover KRMD: 0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $6.75.